<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Abdollahi M</submitter><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>102792</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12794071</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(1)</volume><pubmed_abstract>The long noncoding RNA (lncRNA) lnc-megacluster (lncMGC) is implicated in diabetic kidney disease and pancreatic islet dysfunction. However, its role in obesity and insulin resistance (IR) is unknown. Herein, we investigated the regulatory role of lncMGC in obesity and adipose dysfunction using lncMGC knockout-(KO) mice and further determined the translational potential of lncMGC-based therapeutics for obesity using GapmeR antisense oligonucleotides in wild-type and partially humanized-lncMGC mice. We found lncMGC is upregulated in perigonadal white adipose (gWAT) and brown adipose tissues (BAT) from high-fat diet (HFD)-induced obese mice along with increased endoplasmic reticulum stress signaling. Inhibition of lncMGC in mice via genetic ablation or GapmeRs targeting mouse or human lncMGC</pubmed_abstract><journal>Molecular therapy. Nucleic acids</journal><pubmed_title>Metabolic beneficial effects of targeting a long non-coding RNA, lnc-megacluster, in obesity.</pubmed_title><pmcid>PMC12794071</pmcid><funding_grant_id>R01 DK143577</funding_grant_id><funding_grant_id>R01 DK065073</funding_grant_id><funding_grant_id>P30 CA033572</funding_grant_id><funding_grant_id>R01 DK081705</funding_grant_id><pubmed_authors>Abdollahi M</pubmed_authors><pubmed_authors>Nandi J</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Pillai RK</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Lanting L</pubmed_authors><pubmed_authors>Malek V</pubmed_authors><pubmed_authors>Rezaei A</pubmed_authors><pubmed_authors>Kato M</pubmed_authors><pubmed_authors>Kebrom L</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Tanwar VS</pubmed_authors><pubmed_authors>Ma K</pubmed_authors><pubmed_authors>Natarajan R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolic beneficial effects of targeting a long non-coding RNA, lnc-megacluster, in obesity.</name><description>The long noncoding RNA (lncRNA) lnc-megacluster (lncMGC) is implicated in diabetic kidney disease and pancreatic islet dysfunction. However, its role in obesity and insulin resistance (IR) is unknown. Herein, we investigated the regulatory role of lncMGC in obesity and adipose dysfunction using lncMGC knockout-(KO) mice and further determined the translational potential of lncMGC-based therapeutics for obesity using GapmeR antisense oligonucleotides in wild-type and partially humanized-lncMGC mice. We found lncMGC is upregulated in perigonadal white adipose (gWAT) and brown adipose tissues (BAT) from high-fat diet (HFD)-induced obese mice along with increased endoplasmic reticulum stress signaling. Inhibition of lncMGC in mice via genetic ablation or GapmeRs targeting mouse or human lncMGC</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Mar</publication><modification>2026-06-06T19:36:54.192Z</modification><creation>2026-06-04T03:12:24.748Z</creation></dates><accession>S-EPMC12794071</accession><cross_references><pubmed>41532014</pubmed><doi>10.1016/j.omtn.2025.102792</doi></cross_references></HashMap>